CUSIP: 31773D101
What is CUSIP 31773D101?
CUSIP 31773D101 identifies FNCH - FINCH THERAPEUTICS GROUP INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 31773D101:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q3 | 0 | $0 | -$472,946 | 0 | |
| 2023 Q2 | 55,445 | $472,946 | -$16,815,654 | $8.53 | 1 |
| 2023 Q1 | 9,550,516 | $3,753,787 | -$100,822 | $0.39 | 31 |
| 2022 Q4 | 9,588,250 | $4,602,141 | -$524,990 | $0.48 | 36 |
| 2022 Q3 | 10,040,301 | $16,766,000 | +$224,408 | $1.67 | 37 |
| 2022 Q2 | 9,861,883 | $28,007,000 | -$3,695,799 | $2.84 | 40 |
| 2022 Q1 | 10,553,711 | $53,127,000 | -$4,940,173 | $5.03 | 51 |
| 2021 Q4 | 11,532,788 | $114,971,000 | +$16,355,744 | $9.97 | 49 |
| 2021 Q3 | 8,213,299 | $106,795,000 | +$34,372,847 | $13.00 | 44 |
| 2021 Q2 | 5,512,277 | $77,243,000 | -$20,121,060 | $14.07 | 44 |
| 2021 Q1 | 6,813,126 | $108,890,000 | +$108,883,975 | $16.14 | 36 |